Press Release

Printer Friendly Version View printer-friendly version
<< Back
POZEN Announces Webcast of Fourth Quarter and Full-Year 2002 Results

CHAPEL HILL, N.C.--(BUSINESS WIRE)--Jan. 24, 2003--POZEN Inc. (NASDAQ:POZN), a pharmaceutical development company with a portfolio of product candidates for the treatment of migraine, today announced it will release fourth quarter and full-year 2002 financial results on Thursday, January 30, 2003, before the financial markets open. The release will be followed by a conference call at 11:00 a.m. Eastern time, hosted by John R. Plachetka, chairman, president, and chief executive officer, and Matthew E. Czajkowski, chief financial officer.

The conference call will be simulcast live on the Internet, and can be accessed by logging on to www.pozen.com. A replay will be available for seven days and can be accessed by going to POZEN's website and clicking on Investor Overview.

POZEN is a pharmaceutical development company committed to building a portfolio of products with significant commercial potential in select therapeutic areas. POZEN's initial focus is on developing products for migraine therapy, a global market expected to exceed $3 billion this year. The company's common stock is traded on The Nasdaq Stock Market under the symbol "POZN."

CONTACT:
POZEN Inc.
Matt Czajkowski
Chief Financial Officer
919-913-1030
or
Lisa Barthelemy
Director, Investor Relations
919-913-1044


Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.